JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB284389

Anti-CD133 antibody [RM1029]

  • BOND RX™ Validated
  • 20ul selling size
  • RabMAb
  • Recombinant
  • What is this?

Be the first to review this product! Submit a review

|

(14 Publications)

Rabbit Recombinant Multiclonal CD133 antibody. Suitable for ICC, IP, Flow Cyt, WB, IHC-P, IHC-Fr and reacts with Human, Mouse samples. Cited in 14 publications.

View Alternative Names

CD133, PROML1, MSTP061, PROM1, Prominin-1, Antigen AC133, Prominin-like protein 1

16 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD133 antibody [RM1029] (AB284389)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD133 antibody [RM1029] (AB284389)

Immunohistochemical analysis of paraffin-embedded Human breast tissue labelling CD133 with ab284389 at 1/500 (1.016 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection) was used. Apical staining on human breast. The section was incubated with ab284389 for 30 mins at room temperature.The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.

Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection) was used.

Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD133 antibody [RM1029] (AB284389)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD133 antibody [RM1029] (AB284389)

Immunohistochemical analysis of paraffin-embedded Human pancreatic carcinoma tissue labelling CD133 with ab284389 at 1/500 (1.016 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection) was used. Apical staining on human pancreatic carcinoma. The section was incubated with ab284389 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.

Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection) was used.

Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD133 antibody [RM1029] (AB284389)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD133 antibody [RM1029] (AB284389)

Immunohistochemical analysis of paraffin-embedded Human kidney tissue labelling CD133 with ab284389 at 1/500 (1.016 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection) was used. Positive staining on parietal layer of Bowman's capsule and apical staining on renal tubules in human kidney. The section was incubated with ab284389 for 30 mins at room temperature.The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.

Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection) was used.

Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD133 antibody [RM1029] (AB284389)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD133 antibody [RM1029] (AB284389)

Immunohistochemical analysis of paraffin-embedded Human pancreas tissue labelling CD133 with ab284389 at 1/500 (1.016 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection) was used. Positive staining on the pancreatic ducts in human pancreas. The section was incubated with ab284389 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.

Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection) was used.

Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.

Flow Cytometry - Anti-CD133 antibody [RM1029] (AB284389)
  • Flow Cyt

Lab

Flow Cytometry - Anti-CD133 antibody [RM1029] (AB284389)

Flow cytometric analysis of 293T (Human embryonic kidney epithelial cell, Left), Caco-2 (Human colorectal adenocarcinoma epithelial cell, Right) cells labelling CD133 with ab284389 at 1/500 dilution (0.1ug) (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat anti-Rabbit IgG (Alexa Fluor® 647, ab150083) at 1/2000 dilution was used as the secondary antibody. Negative control : 293T. Gated on viable cells.

Immunocytochemistry - Anti-CD133 antibody [RM1029] (AB284389)
  • ICC

Lab

Immunocytochemistry - Anti-CD133 antibody [RM1029] (AB284389)

Immunofluorescent analysis of 100% methanol-fixed, 0.1% TritonX-100 permeabilized Caco-2 cells labelling CD133 with ab284389 at 1/50 (10.16 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2ug/ml dilution (Green). Confocal image showing membranous staining in Caco-2 cells is observed. ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5ug/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2ug/ml dilution.

Immunoprecipitation - Anti-CD133 antibody [RM1029] (AB284389)
  • IP

Lab

Immunoprecipitation - Anti-CD133 antibody [RM1029] (AB284389)

CD133 was immunoprecipitated from 0.35 mg Caco-2 (Human colorectal adenocarcinoma epithelial cell) whole cell lysate 10ug with ab284389 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab284389 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/5000 dilution.

Lane 1 : Caco-2 (Human colorectal adenocarcinoma epithelial cell) whole cell lysate 10ug

Lane 2 : ab284389 IP in Caco-2 whole cell lysate

Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab284389 in Caco-2 whole cell lysate

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 32 seconds.

All lanes:

Immunoprecipitation - Anti-CD133 antibody [RM1029] (ab284389)

Predicted band size: 97 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD133 antibody [RM1029] (AB284389)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD133 antibody [RM1029] (AB284389)

Immunohistochemical analysis of paraffin-embedded Mouse liver tissue labelling CD133 with ab284389 at 1/2000 (0.254 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection) was used. Positive staining on the biliary ducts of mouse liver. The section was incubated with ab284389 for 30 mins at room temperature.The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.

Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection) was used.

Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins

Immunohistochemistry (Frozen sections) - Anti-CD133 antibody [RM1029] (AB284389)
  • IHC-Fr

Lab

Immunohistochemistry (Frozen sections) - Anti-CD133 antibody [RM1029] (AB284389)

Immunohistochemical analysis of 4% PFA-fixed, 0.2% Triton X-100 permeabilized frozen Mouse E14.5 embryonic kidney tissue labeling CD133 with ab284389 at 1/100 (5.08 ug/ml) dilution followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2 ug/ml dilution (Green). Positive staining on the apical side of mouse E14.5 embryonic kidney buds is observed. The nuclear counterstain was DAPI (Blue).

Secondary antibody control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbedat 1/1000 2 ug/ml dilution.

Heat mediated antigen retrieval using sodium citrate buffer (10mM citrate pH 6.0 + 0.05% Tween-20).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD133 antibody [RM1029] (AB284389)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD133 antibody [RM1029] (AB284389)

Immunohistochemical analysis of paraffin-embedded Mouse breast tissue labelling CD133 with ab284389 at 1/2000 (0.254 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection) was used. Apical staining on mouse breast. The section was incubated with ab284389 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.

Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection) was used.

Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.

Flow Cytometry - Anti-CD133 antibody [RM1029] (AB284389)
  • Flow Cyt

Lab

Flow Cytometry - Anti-CD133 antibody [RM1029] (AB284389)

Flow cytometric analysis of Mouse bone marrow cell cells labelling CD133 with ab284389 at 1/50 dilution (1ug)/ Right compared with a Rabbit monoclonal IgG (ab172730) / Left isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat anti-Rabbit IgG (Alexa Fluor® 647, ab150083) at 1/2000 dilution was used as the secondary antibody. Cells were stained with rabbit IgG or ab271092. Then stained with Lineage cocktail conjugated to FITC, anti-Sca-1 conjugated to PE/Cy7, anti-CD117 conjugated to APC/Cy7 and anti-CD16/32 conjugated to BV510.Gated on viable MP cells. Positive staining on CD16/32+ MP cells is consistent with literature. (PMID : 23509298)

Immunohistochemistry (Frozen sections) - Anti-CD133 antibody [RM1029] (AB284389)
  • IHC-Fr

Lab

Immunohistochemistry (Frozen sections) - Anti-CD133 antibody [RM1029] (AB284389)

Immunohistochemical analysis of 4% PFA-fixed, 0.2% Triton X-100 permeabilized frozen Mouse E14.5 embryonic lung tissue labeling CD133 with ab284389 at 1/100 (5.08 ug/ml) dilution followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2 ug/ml dilution (Green). Positive staining on the apical side of mouse E14.5 embryonic lung buds is observed. The nuclear counterstain was DAPI (Blue).

Secondary antibody control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbedat 1/1000 2 ug/ml dilution.

Heat mediated antigen retrieval using sodium citrate buffer (10mM citrate pH 6.0 + 0.05% Tween-20).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD133 antibody [RM1029] (AB284389)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD133 antibody [RM1029] (AB284389)

Immunohistochemical analysis of paraffin-embedded Mouse retina tissue labelling CD133 with ab284389 at 1/2000 (0.254 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection) was used. Positive staining on the cone and rod cells of mouse retina. The section was incubated with ab284389 for 30 mins at room temperature.The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.

Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection) was used.

Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins

Flow Cytometry - Anti-CD133 antibody [RM1029] (AB284389)
  • Flow Cyt

Lab

Flow Cytometry - Anti-CD133 antibody [RM1029] (AB284389)

Flow cytometric analysis of Mouse bone marrow cell cells labelling CD133 with ab284389 at 1/50 dilution (1ug)/ Right compared with a Rabbit monoclonal IgG (ab172730) / Left isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat anti-Rabbit IgG (Alexa Fluor® 647, ab150083) at 1/2000 dilution was used as the secondary antibody. Cells were co-stained with anti-CD117 conjugated to APC/Cy7. Gated on viable cells.

Immunoprecipitation - Anti-CD133 antibody [RM1029] (AB284389)
  • IP

Lab

Immunoprecipitation - Anti-CD133 antibody [RM1029] (AB284389)

CD133 was immunoprecipitated from 0.35 mg Mouse kidney lysate 10ug with ab284389 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab284389 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/5000 dilution.

Lane 1 : Mouse kidney lysate 10ug

Lane 2 : ab284389 IP in Mouse kidney lysate

Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab284389 in Mouse kidney lysate

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 5 seconds.

All lanes:

Immunoprecipitation - Anti-CD133 antibody [RM1029] (ab284389)

Predicted band size: 97 kDa

false

Western blot - Anti-CD133 antibody [RM1029] (AB284389)
  • WB

Lab

Western blot - Anti-CD133 antibody [RM1029] (AB284389)

Blocking and diluting buffer and concentration : 5%

NFDM/TBST Negative control : MEF (PMID : 21709693)

Similar band pattern was observed in literature. (PMID : 26137114)

Lysate were not boiled to avoid protein aggregation.

All lanes:

Western blot - Anti-CD133 antibody [RM1029] (ab284389) at 1/1000 dilution

Lane 1:

Caco-2 (Human colorectal adenocarcinoma epithelial cell) whole cell lysate at 20 µg

Lane 2:

NCCIT (Human pluripotent embryonic carcinoma epithelial cell) whole cell lysate at 20 µg

Lane 3:

293T (Human embryonic kidney epithelial cell) whole cell lysate at 20 µg

Lane 4:

ES-D3 (Mouse embryo spherical colony) whole cell lysate at 20 µg

Lane 5:

MEF (Mouse embryonic fibroblast (immortalized) whole cell lysate at 20 µg

Lane 6:

F9 (Mouse embryonal carcinoma epithelial cell) whole cell lysate at 20 µg

Lane 7:

Mouse E12.5 brain lysate at 20 µg

Lane 8:

Rat E12.5 brain lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 97 kDa

false

Exposure time: 1min

  • Carrier free

    Anti-CD133 antibody [RM1029] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Multiclonal

Clone number

RM1029

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Human

Applications

ICC, IHC-P, Flow Cyt, WB, IP, IHC-Fr

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICC" : {"fullname" : "Immunocytochemistry", "shortname":"ICC"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IHCFr" : {"fullname" : "Immunohistochemistry (Frozen sections)", "shortname":"IHC-Fr"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICC-species-checked": "testedAndGuaranteed", "ICC-species-dilution-info": "1/50", "ICC-species-notes": "<p>ICC is unsuitable for Mouse</p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1/50", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/500", "IHCP-species-notes": "<p></p>", "IHCFr-species-checked": "guaranteed", "IHCFr-species-dilution-info": "", "IHCFr-species-notes": "" }, "Mouse": { "ICC-species-checked": "guaranteed", "ICC-species-dilution-info": "", "ICC-species-notes": "", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1/50", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/500", "IHCP-species-notes": "<p></p>", "IHCFr-species-checked": "testedAndGuaranteed", "IHCFr-species-dilution-info": "1/100", "IHCFr-species-notes": "<p>Perform heat mediated antigen retrieval with sodium citrate buffer (10mM citrate pH 6.0 + 0.05% Tween-20) before commencing with IHC staining protocol.</p>" }, "Rat": { "ICC-species-checked": "notRecommended", "ICC-species-dilution-info": "", "ICC-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "IHCFr-species-checked": "notRecommended", "IHCFr-species-dilution-info": "", "IHCFr-species-notes": "<p>Perform heat mediated antigen retrieval with sodium citrate buffer (10mM citrate pH 6.0 + 0.05% Tween-20) before commencing with IHC staining protocol.</p>" } } }

Product details

What are recombinant multiclonals?
Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including:

  • - The sensitivity of polyclonal antibodies by recognising multiple epitopes
  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

View our range of recombinant multiclonal antibodies.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CD133 also known as Prominin-1 is a transmembrane glycoprotein with a molecular weight of approximately 120 kDa. This protein stands out due to its expression in various stem and progenitor cells including those of the neural hematopoietic and epithelial lineages. CD133 is recognized for its distinct five transmembrane domains and two large extracellular loops. Researchers commonly use CD133 as a cell surface marker to identify stem and progenitor cells. The significance of CD133 extends to immunohistochemistry (IHC) and Western blot applications where it is a popular target for detection and analysis.
Biological function summary

CD133 is involved in maintaining the cellular architecture and signaling processes. It plays a role in cellular differentiation and proliferation while acting as a part of larger protein complexes on the cell surface. This protein is notable as it contributes significantly to the regulation of stem cell properties supporting the growth and repair in various tissues. Anti-CD133 antibodies are valuable tools in studying these functions due to their specificity in targeting this marker.

Pathways

CD133 participates in cellular signaling and transport pathways vital for intercellular communication and homeostasis. It interacts within pathways related to cell polarity and asymmetric division both essential for tissue development and maintenance. CD133 is associated with proteins like CD133/1 and CD133/2 which further highlights its involvement in these complex biological networks and on pathways such as the Wnt signaling pathway which regulates gene expression associated with cell proliferation and differentiation.

Several studies indicate a strong relationship between CD133 expression and certain cancers such as glioblastoma and colorectal cancer. In these cases CD133 serves not only as a marker but also as an indicator of the presence of cancer stem cells which are capable of tumor initiation and maintenance. Furthermore researchers have identified connections between CD133 and other proteins such as c-Met (cMab) within these pathological contexts suggesting interactions that could contribute to disease progression and offering potential targets for therapeutic intervention.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

May play a role in cell differentiation, proliferation and apoptosis (PubMed : 24556617). Binds cholesterol in cholesterol-containing plasma membrane microdomains and may play a role in the organization of the apical plasma membrane in epithelial cells. During early retinal development acts as a key regulator of disk morphogenesis. Involved in regulation of MAPK and Akt signaling pathways. In neuroblastoma cells suppresses cell differentiation such as neurite outgrowth in a RET-dependent manner (PubMed : 20818439).
See full target information PROM1

Publications (14)

Recent publications for all applications. Explore the full list and refine your search

Communications biology 8:975 PubMed40595410

2025

circGIGYF1 inhibits stemness and metastasis in colorectal cancer by promoting WWP2-HOXD13 interaction to regulate β-catenin signalling.

Applications

Unspecified application

Species

Unspecified reactive species

Bin Zhao,Jiacheng Li,Zunxian Wang,Hairui Zhou,Zhuoxin Cheng,Shuxia Ma

Heliyon 11:e42095 PubMed39916855

2025

Dihydroartemisinin inhibits EphA2/PI3K/Akt pathway-mediated malignant behaviors and vasculogenic mimicry in glioma stem cells.

Applications

Unspecified application

Species

Unspecified reactive species

Huangde Fu,Shengtian Wu,Hechun Shen,Kai Luo,Zhongxiang Huang,Nankun Lu,Yaolin Li,Qian Lan,Yishun Xian

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 12:e2406935 PubMed39582289

2024

mA Reader PRRC2A Promotes Colorectal Cancer Progression via CK1ε-Mediated Activation of WNT and YAP Signaling Pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Xi Wu,Shiyang Wang,Yuwei Pan,Mengzhen Li,Manyu Song,Hanfu Zhang,Min Deng,Xu Yang,Jiuzhi Xu,Shuo Zhang,Jinhua Zhang,Fengchao Wang,Maksim V Plikus,Cong Lv,Lu Yu,Zhengquan Yu

Heliyon 10:e30330 PubMed38726177

2024

NAT10-mediated acC modification promotes stemness and chemoresistance of colon cancer by stabilizing NANOGP8.

Applications

Unspecified application

Species

Unspecified reactive species

Li-Ping Gao,Ting-Dong Li,Su-Zhen Yang,Hui-Min Ma,Xiang Wang,De-Kui Zhang

Cancer cell international 24:121 PubMed38555451

2024

β-hydroxybutyrate inhibits malignant phenotypes of prostate cancer cells through β-hydroxybutyrylation of indoleacetamide-N-methyltransferase.

Applications

Unspecified application

Species

Unspecified reactive species

Yifan Zhang,Yunlong Li

iScience 27:108447 PubMed38292422

2024

circCD2AP promotes epithelial mesenchymal transition and stemness in bladder cancer by regulating FOXQ1/USP21 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Jinrong Wang,Jing Tan,Yichuan Zhang,Lei Zhou,Yuan Liu

Advanced healthcare materials 13:e2303337 PubMed38154036

2023

Nanointegrative Glycoengineering-Activated Necroptosis of Triple Negative Breast Cancer Stem Cells Enables Self-Amplifiable Immunotherapy for Systemic Tumor Rejection.

Applications

Unspecified application

Species

Unspecified reactive species

Youbo Zhao,Yanan Li,Jing He,Menghuan Li,Xuemei Yao,Huocheng Yang,Zhong Luo,Peng Luo,Min Su

Advanced materials (Deerfield Beach, Fla.) 36:e2304935 PubMed37589665

2023

Printed Divisional Optical Biochip for Multiplex Visualizable Exosome Analysis at Point-of-Care.

Applications

Unspecified application

Species

Unspecified reactive species

Xu Yang,Zeying Zhang,Yuanbin Wu,Huadong Wang,Yang Yun,Yali Sun,Hongfei Xie,Bogdan Bogdanov,Pavel Senyushkin,Jimei Chi,Zewei Lian,Dongdong Wu,Meng Su,Yanlin Song

Molecular therapy : the journal of the American Society of Gene Therapy 31:3067-3083 PubMed37533253

2023

Single-cell dissection of cellular and molecular features underlying mesenchymal stem cell therapy in ischemic acute kidney injury.

Applications

Unspecified application

Species

Unspecified reactive species

Wenjuan Wang,Min Zhang,Xuejing Ren,Yanqi Song,Yue Xu,Kaiting Zhuang,Tuo Xiao,Xinru Guo,Siyang Wang,Quan Hong,Zhe Feng,Xiangmei Chen,Guangyan Cai

Cancers 15: PubMed37370759

2023

METTL3-Modulated Promotes Colorectal Cancer Stemness and Metastasis through Increasing mRNA Stability by Recruiting IGF2BP1.

Applications

Unspecified application

Species

Unspecified reactive species

Miao Chen,Buning Tian,Gui Hu,Yihang Guo
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com